Skip to content
OpenCapital
Get started

Cyclerion Therapeutics CYCN Q1 2025 earnings

Reported May 6, 2025 · Before market open

Revenue$81.0KDiluted EPS-$0.56

Next report

Aug 4, 2026 (In 3 weeks)
Revenue estimate$1.5M
EPS estimate-$7.10

Versus estimates

Revenue

Q4 2025$100.0KIn lineQ1 2024$100.0KIn lineQ3 2025$875.0KQ2 2025$93.0K
Q1 2025$81.0K

Diluted EPS

Q1 2026-$0.76Beat by $16.44Q4 2025-$0.19Beat by $0.19Q1 2024-$0.38In lineQ3 2025-$0.30Q2 2025-$0.11
Q1 2025-$0.56

Ask the moment Cyclerion Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cyclerion Therapeutics report Q1 2025 earnings?
Cyclerion Therapeutics (CYCN) reported Q1 2025 earnings on May 6, 2025 before market open.
What were Cyclerion Therapeutics's Q1 2025 revenue and EPS?
Cyclerion Therapeutics reported revenue of $81.0K and diluted EPS of $-0.56 for Q1 2025.
How did Cyclerion Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 19.0% from $100.0K a year earlier and diluted EPS declined 47.4% from $-0.38.
Where can I find Cyclerion Therapeutics's Q1 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-064493) directly on SEC EDGAR. The filing index links above go to sec.gov.